Page 66 - Read Online
P. 66

Martin et al. Microbiome Res Rep 2023;2:17  https://dx.doi.org/10.20517/mrr.2023.10  Page 3 of 13

               arabinogalactans [31,32] . Bifidobacterium  and  Bacteroides  species  are  the  primary  degraders  of  these
                            [25]
               polysaccharides , and molecular mechanisms have been resolved in part. Although utilization of plant-
               derived oligosaccharides is common among gut microbes, recent studies have increased our understanding
               of the molecular adaptations of these genera to use more complex polysaccharides, especially host-derived
               glycans . These findings highlight the ability of Bifidobacterium and Bacteroides to adapt to the intestinal
                     [33]
               environment. One of these complex substrates is human milk oligosaccharides (HMOs), an important
               carbon source for Bifidobacterium provided to infants via breast milk. HMOs are composed of lactose with
               repetitions of N-acetylglucosamine, fucose, and sialic acid. HMOs have a strong bifidogenic effect, which
               can be explained by multiple molecular adaptations in their genomes, including ABC transporters and
               specialized glycosyl hydrolases. The gut microbiota can also target other host-derived dietary substrates
                                                [33]
               such as mucins and milk glycoproteins . N- and O-Glycans found in IgA and mucins can be accessed and
               used  as  carbon  and  energy  sources  for  bacteria  such  as  Bifidobacterium  bifidum, Bacteroides
               thetaiotaomicron, and Akkermansia muciniphila .
                                                        [34]

               Microbiome-derived metabolites influence several physiological processes within the host. The gut
                                                                                         [35]
               microbiome produces millimolar concentrations of short-chain fatty acids (SCFAs) , such as acetate,
               propionate, and butyrate. Their concentrations vary in different segments of the intestine and are released
               in a ratio of 3:1:1 for acetate, propionate, and butyrate [35,36] . Other acids, such as lactate and succinate, are
               considered intermediates in gut microbiota metabolism and participate in cross-feeding reactions, generally
               absent in fecal samples [37-39] . Bifidobacterium central metabolism, the bifid shunt, theoretically produces
                                                                                         [40]
               acetate and lactate in a 3:2 ratio, together with 2.5 moles of ATP per mole of glucose . This ratio could
               indeed show variations according to the dietary source. In addition, Bifidobacterium has been found to
               contribute significantly to butyrate and propionate production through different mechanisms of cross-
               feeding with other gut bacteria [41-45] . Other end-products, such as ethanol, succinate, and formate, are
               commonly produced by these species. For instance, the fermentation of fucose by Bifidobacterium results in
               formate production in the infant gut . Recently, aromatic lactic acids derived from infant-associated
                                                [39]
               Bifidobacterium, such as indole lactic acid, were found to have a strong immunomodulatory effect on CD4+
               T cells by activating the aryl hydrocarbon receptor, AhR .
                                                              [46]
               SCFAs maintain host intestinal homeostasis because of their anti-inflammatory and protective effects on the
               intestinal epithelium, and participate in the regulation of multiple cellular processes [4,47,48] . Acetate is
               absorbed by the epithelium and reaches systemic micromolar concentrations. Propionate is primarily used
               in the liver . Butyrate is the primary energy source for the colonic epithelium [49,50]  and its utilization by host
                        [35]
               cells requires oxygen, thereby contributing to luminal anaerobiosis . Additionally, butyrate is an epigenetic
                                                                       [49]
               regulator that inhibits histone deacetylases in colonocytes  and suppresses inflammatory pathways via G-
                                                                [51]
               protein-coupled receptors . Butyrate can be synthesized by four distinct metabolic pathways. Most
                                      [52]
               butyrate-producing bacteria (BPB) contain butyrate kinase or butyryl-CoA: acetate-CoA transferase .
                                                                                                       [53]
               Moreover, BPB are considered critical species in the gut microbiota and essential for its stability and
               function [54-56] . BPB includes microorganisms from unrelated genera, representing a more functional than
               taxonomic  category . Representative  BPB  include  Anaerostipes  caccae, Roseburia  intestinalis,
                                  [57]
               Lachnoclostridium  symbiosum, Faecalibacterium  prausnitzii, Clostridium  saccharolyticum  among
                                                                         [41]
               others [58,59] . BPB are highly oxygen-sensitive Gram-positive bacteria  that, while capable of using simple
               oligosaccharides, appear to prefer molecules such as lactate, succinate, or acetate to produce butyrate [54,60] .
               Although BPB have beneficial effects, and a decrease in their abundance can be an indicator of declining
               intestinal health and response to microbial diseases [12,61] , the role of butyrate in host physiology has been
               controversial due to conflicting evidence in the literature. Variations in diet, gut microbiota composition,
               and individual genetic differences may also play a role in determining the effects of butyrate in a dose-
   61   62   63   64   65   66   67   68   69   70   71